Table 1 Standards, criteria and targets used in gout audit
Theme of care | Guideline statement | Criteria | Standards |
|---|---|---|---|
Assessment of gout patients | All patients presenting with acute gout should have SUA, renal function and glucose assessed 4-6wk after acute attack [3] | 1.1 Adult patients with a diagnosis of gout have ever had a recorded SUA | ≥90% |
1.2 Adult patients with a diagnosis of gout have ever had a recorded eGFR | ≥90% | ||
1.3 Adult patients with a diagnosis of gout have had a recorded serum glucose since diagnosis | ≥90% | ||
Management of recurrent gout | The therapeutic goal of urate lowering therapy…is achieved by maintaining the SUA below the saturation point for urate (≤360 μmol/l) [4] | 2.1 Adult patients currently prescribed (prescription in the last 2 months) allopurinol have a SUA measured in the last year | ≥90% |
2.2 Adult patients currently prescribed (prescription in the last 2 months) allopurinol have an SUA ≤ 360 μmol/l | ≥80% | ||
Monitoring of gout patients | Annual measurements of plasma renal function and SUA [3] | 3.1 Adult patients with a diagnosis of gout have had a SUA in the last year | ≥90% |
3.2 Adult patients with a diagnosis of gout have had a eGFR measured in the last year | ≥90% | ||
Lifestyle advice | All patients with gout should be given advice about diet, alcohol restriction, weight management and fluid intake.[3, 4] | 4.1 Adult patients with a diagnosis of gout with evidence of advice regarding diet recorded | ≥90% |
[It is recognised that such information may be provided in written format in a patient information leaflet] | 4.2 Adult patients with a diagnosis of gout with evidence of advice regarding alcohol recorded | ≥90% | |
4.3 Adult patients with a diagnosis of gout with evidence of advice regarding fluid intake recorded | ≥90% | ||
4.4 Adult patients with a diagnosis of gout have a record of BMI | ≥90% | ||
Addressing comorbidities | Associated comorbidities and cardiovascular risk factors should be addressed as an important part of the management of gout [4] | 5.1 Adult patients with a diagnosis of gout have a recorded CVD risk assessment score | ≥90% |
5.2 Adult patients with a diagnosis of gout and a 10 yr risk of CVD ≥20% are prescribed lipid lowering therapy | ≥75% | ||
Diuretic therapy should be stopped if possible in patients with a diagnosis of gout [3, 4] | 5.3 Adult patients with a diagnosis of gout currently taking diuretics | <25% |